Immune checkpoint inhibitor (ICI) reuse after failure of first-line ICI in patients with metastatic dMMR/MSI gastrointestinal cancers: The INFLATE study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Léa Mercier, Filippo Pietrantonio, Edouard Auclin, Michael J. Overman, Emily Linda Alouani, Antoine Hollebecque, Sara Lonardi, Frank A. Sinicrope, David Tougeron, Marie Dutherage, Anthony Turpin, Thibault Mazard, Francesco Sclafani, Priya Jayachandran, Javier Ros Montañá, Lola Jade Palmieri, Rosine Guimbaud, Julien Taieb, Simon Pernot
Institutions: Institut Bergonié, Fondazione IRCCS Istituto Nazionale dei Tumori, The University of Texas MD Anderson Cancer Center, Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud, Institut Gustave Roussy, Istituto Oncologico Veneto, Mayo Clinic, Centre Hospitalier Universitaire de Poitiers, Centre Hospitalier Universitaire de Rouen, Centre Hospitalier Universitaire de Lille, Institut Regional du Cancer de Montpellier, Université Libre de Bruxelles, Institut Jules Bordet, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Centre Hospitalier Universitaire de Toulouse, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410805387